Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 254

    1.

    Institutional review boards: a crisis in confidence.

    Levine RJ.

    Ann Intern Med. 2001 Jan 16;134(2):161-3. No abstract available. PMID: 11177321 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Breaking the camel's back: multicenter clinical trials and local institutional review boards.

    Burman WJ, Reves RR, Cohn DL, Schooley RT.

    Ann Intern Med. 2001 Jan 16;134(2):152-7.PMID: 11177319 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Balancing caution & courage. Physicians and regulators weigh informed consent issues in clinical research.

    Montague J.

    Hosp Health Netw. 1994 Sep 20;68(18):50, 52-4. No abstract available. PMID: 8081420 [PubMed - indexed for MEDLINE]Related articles

    4.

    Variability among institutional review boards and the value of local research context.

    Clark DC.

    Crit Care Med. 2001 Feb;29(2):444-5. No abstract available. PMID: 11246330 [PubMed - indexed for MEDLINE]Related articles

    5.

    Clinical trial monitoring: hit or miss?

    Cohen J.

    Science. 1994 Jun 10;264(5165):1534-7. No abstract available. PMID: 8202707 [PubMed - indexed for MEDLINE]Related articles

    6.

    IRBs search for answers and support during a time of institutional change.

    Phillips DF.

    JAMA. 2000 Feb 9;283(6):729-30. No abstract available. PMID: 10683041 [PubMed - indexed for MEDLINE]Related articles

    7.

    Variation in institutional review board responses to a standard protocol for a multicenter clinical trial.

    Stair TO, Reed CR, Radeos MS, Koski G, Camargo CA; MARC Investigators. Multicenter Airway Research Collaboration.

    Acad Emerg Med. 2001 Jun;8(6):636-41.PMID: 11388939 [PubMed - indexed for MEDLINE]Related articles

    8.

    Protection of human subjects; standards for institutional review boards for clinical investigations--Food and Drug Administration. Final rule.

    [No authors listed]

    Fed Regist. 1981 Jan 27;46(17 pt 2):8958-79.PMID: 10249529 [PubMed - indexed for MEDLINE]Related articles

    9.

    Rapid reporting and review of an increased incidence of a known adverse event.

    Sargent DJ, Goldberg RM, Mahoney MR, Hillman DW, McKeough T, Hamilton SF, Darcy JM, Anderson VL, Krook JE, O'Connell MJ.

    J Natl Cancer Inst. 2000 Jun 21;92(12):1011-3. No abstract available. PMID: 10861314 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The role of local institutional review boards in protecting human research subjects.

    Burman WJ, Schooley RT.

    JAMA. 2001 Jun 6;285(21):2713. No abstract available. PMID: 11386919 [PubMed - indexed for MEDLINE]Related articles

    11.

    Site visit monitoring program of the clinical cooperative groups: results of the first 3 years.

    Mauer JK, Hoth DF, Macfarlane DK, Hammershaimb LD, Wittes RE.

    Cancer Treat Rep. 1985 Oct;69(10):1177-87. No abstract available. PMID: 4042096 [PubMed - indexed for MEDLINE]Related articles

    12.

    Requiring institutions to inform participants who have completed therapy on SWOG-8892 (RT +/- cisplatin for nasopharyngeal cancer) about early study closure: right idea, wrong patients.

    Amdur RJ, Bankert E.

    Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):673. No abstract available. PMID: 9231694 [PubMed - indexed for MEDLINE]Related articles

    13.

    Institutional review boards must conduct safety review.

    Maloney DM.

    Hum Res Rep. 2005 Feb;20(2):3. No abstract available. PMID: 15839005 [PubMed - indexed for MEDLINE]Related articles

    14.

    Growing pains: central review board project still developing.

    Randal J.

    J Natl Cancer Inst. 2003 May 7;95(9):636-7. No abstract available. PMID: 12734305 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The use of external monitoring committees in clinical trials of the National Institute of Allergy and Infectious Diseases.

    Ellenberg SS, Myers MW, Blackwelder WC, Hoth DF.

    Stat Med. 1993 Mar;12(5-6):461-7; discussion 469.PMID: 8493424 [PubMed - indexed for MEDLINE]Related articles

    16.

    Gene therapy for rare diseases.

    [No authors listed]

    Nat Genet. 1999 Aug;22(4):313-4. No abstract available. PMID: 10431225 [PubMed - indexed for MEDLINE]Related articles

    17.

    A survey of monitoring practices in cancer clinical trials.

    George SL.

    Stat Med. 1993 Mar;12(5-6):435-50.PMID: 8493422 [PubMed - indexed for MEDLINE]Related articles

    19.

    NCI begins overhaul of late-stage cancer trials.

    Ault A.

    Nat Med. 1998 Nov;4(11):1219. No abstract available. PMID: 9809532 [PubMed - indexed for MEDLINE]Related articles

    20.

    LSU and Tulane suspended from NSABP studies.

    [No authors listed]

    J Natl Cancer Inst. 1994 May 18;86(10):750-1. No abstract available. PMID: 8169972 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data